J Korean Soc Neonatol.  2012 May;19(2):53-64. 10.5385/jksn.2012.19.2.53.

Antimicrobial Management of Neonatal Sepsis

Affiliations
  • 1Division of Neonatology, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea. arkim@amc.seoul.kr

Abstract

Neonatal infections are frequent complications of neonates receiving intensive care unit. In particular, large cohort study has suggested that neonatal infections among extremely low birth weight infants are associated with poor neurodevelopmental and growth outcomes in early childhood. This review article will focus on the rational use of empirical antibiotics/antifungal therapy for early and late onset sepsis/fungemia, duration of antibiotic treatment, highlight clinically relevant aspects of the antibiotics commonly used in the treatment of sepsis, antibiotics requiring therapeutic dose monitoring, and management of antibiotic-resistant infection in the neonate.

Keyword

Neonate; Sepsis; Antibiotics; Therapeutic drug monitoring; Resistance

MeSH Terms

Anti-Bacterial Agents
Cohort Studies
Drug Monitoring
Humans
Infant
Infant, Low Birth Weight
Infant, Newborn
Intensive Care Units
Sepsis
Anti-Bacterial Agents
Full Text Links
  • JKSN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr